Synergistic FRET assays for drug discovery targeting RyR2 channels

A key therapeutic target for heart failure and arrhythmia is the deleterious leak through sarcoplasmic reticulum (SR) ryanodine receptor 2 (RyR2) calcium release channels. We have previously developed methods to detect the pathologically leaky state of RyR2 in adult cardiomyocytes by monitoring RyR2...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebbeck, RobynT., Ginsburg, Kenneth S., Ko, Christopher Y., Fasoli, Anna, Rusch, Katherine, Cai, George F., Dong, Xiaoqiong, Thomas, David D., Bers, Donald M., Cornea, Razvan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088286/
https://www.ncbi.nlm.nih.gov/pubmed/35405106
http://dx.doi.org/10.1016/j.yjmcc.2022.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088286/
https://www.ncbi.nlm.nih.gov/pubmed/35405106
http://dx.doi.org/10.1016/j.yjmcc.2022.04.002

Ejemplares similares